These data confirms that sortilin promotes GBM invasion possibly via GSK-3β/β-catenin/Twist-induced mesenchymal transition in vivo, whereas AF38469 impairs GBM invasion and mesenchymal transition, and prolongs the survival time of GBM-bearing mice (Fig. 8). The gene discussed is GSK3B; the disease is glioblastoma.